Literature DB >> 10092309

VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis.

M Sans1, J Panés, E Ardite, J I Elizalde, Y Arce, M Elena, A Palacín, J C Fernández-Checa, D C Anderson, R Lobb, J M Piqué.   

Abstract

BACKGROUND & AIMS: The molecular mechanisms responsible for leukocyte recruitment in experimental colitis are poorly understood. The aims of this study were to measure expression of endothelial intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) and to determine their role in leukocyte recruitment in experimental colitis.
METHODS: Rats with trinitrobenzene sulfonic acid (TNBS)-induced colitis and control rats were studied 1, 7, or 21 days after treatment. ICAM-1 and VCAM-1 expressions were measured by the double radiolabeled antibody technique. Leukocyte-endothelial cell interactions were determined in colonic venules by fluorescence intravital microscopy. Therapeutic effects of treatment with anti-VCAM-1 antibodies were also assessed.
RESULTS: Colonic endothelial ICAM-1 was constitutively expressed and did not increase in colitic animals. In contrast, constitutive expression of VCAM-1 was low but markedly increased (6-fold) 1 and 7 days after induction of colitis. Increased colonic expression of VCAM-1 paralleled macroscopic damage score, myeloperoxidase activity, and increased leukocyte adhesion in colonic venules. The latter was significantly decreased by immunoneutralization of ICAM-1 and completely abrogated by immunoneutralization of VCAM-1. Long-term administration of anti-VCAM-1 antibody resulted in significant attenuation of colitis.
CONCLUSIONS: Induction of colitis in rats by TNBS is followed by up-regulation of endothelial VCAM-1. VCAM-1 and constitutive ICAM-1 are major determinants of leukocyte recruitment to the inflamed intestine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092309     DOI: 10.1016/s0016-5085(99)70070-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  50 in total

1.  Abscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltration.

Authors:  Amir J Guri; Raquel Hontecillas; Josep Bassaganya-Riera
Journal:  Clin Nutr       Date:  2010-03-16       Impact factor: 7.324

2.  In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1.

Authors:  K Matsuzaki; Y Tsuzuki; H Matsunaga; T Inoue; J Miyazaki; R Hokari; Y Okada; A Kawaguchi; S Nagao; K Itoh; S Matsumoto; S Miura
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

3.  Adhesion molecules in chronic ulcerative colitis.

Authors:  Maya V Gulubova; Irena M Manolova; Tatyana I Vlaykova; Margarita Prodanova; Jovcho P Jovchev
Journal:  Int J Colorectal Dis       Date:  2006-11-16       Impact factor: 2.571

Review 4.  Radiation-induced intestinal inflammation.

Authors:  Meritxell Molla; Julian Panes
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

Review 5.  Leukocyte adhesion molecules in animal models of inflammatory bowel disease.

Authors:  Jesús Rivera-Nieves; Gezahegn Gorfu; Klaus Ley
Journal:  Inflamm Bowel Dis       Date:  2008-12       Impact factor: 5.325

6.  Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.

Authors:  Iñigo Valiente-Alandi; Sarah J Potter; Ane M Salvador; Allison E Schafer; Tobias Schips; Francisco Carrillo-Salinas; Aaron M Gibson; Michelle L Nieman; Charles Perkins; Michelle A Sargent; Jiuzhou Huo; John N Lorenz; Tony DeFalco; Jeffery D Molkentin; Pilar Alcaide; Burns C Blaxall
Journal:  Circulation       Date:  2018-09-18       Impact factor: 29.690

7.  Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis.

Authors:  Hao Yuan; Wan-Sheng Ji; Ke-Xiang Wu; Jian-Xin Jiao; Liang-Hua Sun; Yong-Tang Feng
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

8.  ICAM-1 and VCAM-1 antisense oligonucleotides attenuate in vivo leucocyte adherence and inflammation in rat inflammatory bowel disease.

Authors:  E Rijcken; C F Krieglstein; C Anthoni; M G Laukoetter; R Mennigen; H U Spiegel; N Senninger; C F Bennett; G Schuermann
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

9.  The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease.

Authors:  Amir J Guri; Saroj K Mohapatra; William T Horne; Raquel Hontecillas; Josep Bassaganya-Riera
Journal:  BMC Gastroenterol       Date:  2010-06-10       Impact factor: 3.067

10.  Contribution of bone marrow-derived cells to the pro-inflammatory effects of protease-activated receptor-2 in colitis.

Authors:  Eric Hyun; Patricia Andrade-Gordon; Martin Steinhoff; Paul L Beck; Nathalie Vergnolle
Journal:  Inflamm Res       Date:  2010-03-26       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.